Please provide your email address to receive an email when new articles are posted on . Aspirin did not improve DFS for individuals with colorectal cancer liver metastases compared with placebo. OS ...

The efficacy of watch and wait strategy or surgery after neoadjuvant immunotherapy for locally advanced colorectal cancer with dMMR/MSI-H guided by ctDNA dynamic monitoring (WINDOW): A single-center, ...

Resection of liver metastases is considered the only treatment with curative potential for patients with metastatic colorectal cancer to the liver (CRLM). However, only a minority of patients with ...

PDS01ADC is a tumor-targeted IL-12 immunocytokine designed to activate the immune system directly within the tumor microenvironment. By delivering IL-12 — a potent immune-stimulating molecule — to the ...

(A) It was shown low expression of OXCT1 in liver metastasis in datasets GSE41258, GSE68468, GSE35834. Student's t - test was used to calculate p value. (B) The expression of OXCT1 was low in paired ...

A new international study led by Mayo Clinic researchers has identified a genetic factor that may explain why some patients with colorectal cancer that has spread to the liver experience more severe ...

Determining whether a cancerous tumor originated in a given location or spread there from another tissue or organ in the body is important when assessing the likely course of a patient's disease. When ...

French data show multiple-site metastases in colorectal cancer patients under 40 rose 10% annually from 2004–2021, with no survival gains for peritoneal cases. Other research highlights include ...

Aspirin reduces the risk of colon cancer recurrence after surgery, but only in patients with a specific genetic marker ...